UBI.AX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 liep. 2024 @ 03:18):
Our systems believe the stock currently is overvalued by -0.11% compare to its pairs and should correct downwards.

Stats
Dzisiejszy wolumen	42 111
Średni wolumen	337 415
Kapitalizacja rynkowa	34.71M
EPS	$-0.0161 ( Q1 \| 2024-03-31 )
Następna data zysków	( $0 ) 2024-07-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.00 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

AHX.AX -2.90%

ALC.AX 6.25%

ANN.AX -2.41%

AT1.AX 0.00%

AVR.AX 0.00%

CAJ.AX -4.76%

CAU.AX 0.00%

CDX.AX -7.14%

CGS.AX -0.89%

COH.AX -2.89%

CYC.AX -6.51%

EBO.AX -1.81%

EHE.AX 0.33%

EMD.AX 12.20%

EMV.AX -11.11%

FPH.AX -1.26%

HLA.AX 0.17%

HLS.AX -4.33%

HMD.AX 13.04%

IBX.AX -1.18%

IDX.AX -3.00%

IHL.AX -10.87%

IMR.AX -0.94%

IPD.AX -1.39%

M7T.AX -0.78%

MDR.AX -5.00%

MVF.AX -3.11%

MX1.AX -3.61%

NAN.AX -4.01%

NTI.AX 1.43%

NXS.AX -6.38%

ONE.AX -3.75%

PCK.AX 3.70%

PME.AX -5.31%

PNV.AX -4.90%

PSQ.AX -0.79%

REG.AX -3.21%

RHC.AX -1.60%

RHY.AX -3.23%

RSH.AX 13.04%

SHL.AX -2.43%

SIG.AX -2.35%

SNZ.AX 0.81%

TTB.AX 0.00%

UBI.AX 0.00%

VHT.AX 0.44%

VTI.AX 0.00%

Korelacja (AI algo v.1.1b): Overvalued: -0.11% $0.150 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Universal Biosensors, Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Universal Biosensors, Finanse

Annual	2023
Przychody:	$6.63M
Zysk brutto:	$3.32M (50.05 %)
EPS:	$-0.0317

FY	2023
Przychody:	$6.63M
Zysk brutto:	$3.32M (50.05 %)
EPS:	$-0.0317

FY	2022
Przychody:	$4.52M
Zysk brutto:	$2.14M (47.27 %)
EPS:	$-0.140

FY	2021
Przychody:	$5.78M
Zysk brutto:	$2.11M (36.44 %)
EPS:	$-0.0592

Financial Reports:

No articles found.

Universal Biosensors, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Universal Biosensors,

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips; and distributes Siemens' Xprecia Stride Coagulation Analyzer, a test used to monitor the effect of the anticoagulant therapy warfarin. The company also manufactures and distributes Sentia SO2 test strips; and distributes Sentia Analyzer for the use in measurement of free SO2 levels in post-fermentation wine. In addition, it offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.